FDA approves first generic version of Teva's MS drug Copaxone

(Reuters) - Momenta Pharmaceuticals Inc said the U.S. Food and Drug Administration approved the first generic version of Teva Pharmaceuticals Industries Ltd's top-selling multiple sclerosis drug, Copaxone. The agency cleared the application for the 20 mg version of the blockbuster drug, submitted by Momenta's partner Sandoz, a unit of Swiss drugmaker Novartis AG. The generic version, called Glatopa, was developed under a collaboration agreement between Momenta and Sandoz. (Reporting by Natalie Grover in Bengaluru; Editing by Don Sebastian)



via Health News Headlines - Yahoo News http://ift.tt/1HbQQXd